Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
Leo Miller

QURE: Why Analysts See Up to 63% Upside After 250% Single-Day Pop

In one of the most incredible single-day moves this year, biotechnology stock uniQure (NASDAQ: QURE) surged by 284% on Sept. 24. This came as the firm released fantastic clinical results for its developmental medicine, AMT-130.

With such a massive spike, uniQure is turning the heads of Wall Street analysts. Most still see upside, implying a high-risk, high-reward opportunity for investors.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.